Wall Street analysts expect Healthcare Realty Trust Inc (NYSE:HR) to report $111.20 million in sales for the current quarter, according to Zacks Investment Research. Four analysts have made estimates for Healthcare Realty Trust’s earnings. The highest sales estimate is $112.42 million and the lowest is $109.79 million. Healthcare Realty Trust reported sales of $106.95 million in the same quarter last year, which suggests a positive year over year growth rate of 4%. The firm is scheduled to report its next earnings report on Wednesday, November 7th.

According to Zacks, analysts expect that Healthcare Realty Trust will report full-year sales of $447.28 million for the current fiscal year, with estimates ranging from $441.02 million to $451.00 million. For the next financial year, analysts anticipate that the business will report sales of $465.83 million per share, with estimates ranging from $455.29 million to $479.62 million. Zacks Investment Research’s sales calculations are a mean average based on a survey of sell-side research analysts that that provide coverage for Healthcare Realty Trust.

Healthcare Realty Trust (NYSE:HR) last announced its quarterly earnings results on Thursday, August 2nd. The real estate investment trust reported $0.30 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.40 by ($0.10). The firm had revenue of $111.60 million for the quarter, compared to analyst estimates of $111.00 million. Healthcare Realty Trust had a return on equity of 0.72% and a net margin of 2.95%. The firm’s quarterly revenue was up 6.0% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.39 EPS.

HR has been the subject of several research reports. Capital One Financial initiated coverage on shares of Healthcare Realty Trust in a report on Thursday, June 28th. They issued an “equal weight” rating and a $30.00 target price for the company. Morgan Stanley downgraded shares of Healthcare Realty Trust from an “overweight” rating to an “equal weight” rating and dropped their target price for the company from $29.00 to $28.00 in a report on Thursday, August 16th. Mizuho reiterated a “hold” rating and issued a $28.00 target price on shares of Healthcare Realty Trust in a report on Monday, August 13th. Zacks Investment Research upgraded shares of Healthcare Realty Trust from a “sell” rating to a “hold” rating in a report on Friday, August 10th. Finally, ValuEngine upgraded shares of Healthcare Realty Trust from a “sell” rating to a “hold” rating in a report on Thursday, July 5th. Nine research analysts have rated the stock with a hold rating and one has issued a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average target price of $29.25.

Healthcare Realty Trust stock traded up $0.10 during trading on Friday, hitting $30.01. The company had a trading volume of 37,696 shares, compared to its average volume of 636,338. Healthcare Realty Trust has a 1-year low of $26.09 and a 1-year high of $34.13. The company has a debt-to-equity ratio of 0.76, a quick ratio of 0.11 and a current ratio of 0.11. The company has a market capitalization of $3.78 billion, a PE ratio of 19.54, a price-to-earnings-growth ratio of 4.76 and a beta of 0.15.

The business also recently announced a quarterly dividend, which was paid on Thursday, August 30th. Investors of record on Wednesday, August 15th were issued a $0.30 dividend. The ex-dividend date was Tuesday, August 14th. This represents a $1.20 annualized dividend and a yield of 4.00%. Healthcare Realty Trust’s dividend payout ratio (DPR) is presently 78.43%.

In other Healthcare Realty Trust news, EVP John M. Bryant, Jr. sold 2,561 shares of the firm’s stock in a transaction that occurred on Thursday, August 9th. The shares were sold at an average price of $30.56, for a total value of $78,264.16. Following the completion of the transaction, the executive vice president now owns 146,795 shares of the company’s stock, valued at approximately $4,486,055.20. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 1.85% of the stock is currently owned by company insiders.

A number of hedge funds have recently modified their holdings of the business. Qube Research & Technologies Ltd purchased a new stake in shares of Healthcare Realty Trust during the 2nd quarter worth $112,000. Advisors Asset Management Inc. lifted its position in shares of Healthcare Realty Trust by 725.6% during the 2nd quarter. Advisors Asset Management Inc. now owns 36,259 shares of the real estate investment trust’s stock worth $135,000 after purchasing an additional 31,867 shares during the last quarter. Hartford Investment Management Co. purchased a new stake in shares of Healthcare Realty Trust during the 2nd quarter worth $229,000. Bank of Montreal Can purchased a new stake in shares of Healthcare Realty Trust during the 2nd quarter worth $242,000. Finally, Paloma Partners Management Co purchased a new stake in shares of Healthcare Realty Trust during the 2nd quarter worth $293,000. 93.85% of the stock is owned by institutional investors.

About Healthcare Realty Trust

Healthcare Realty Trust is a real estate investment trust that integrates owning, managing, financing and developing income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States. As of June 30, 2018, the Company owned 201 real estate properties in 27 states totaling 14.9 million square feet and was valued at approximately $5.0 billion.

Further Reading: Average Daily Trade Volume – ADTV

Get a free copy of the Zacks research report on Healthcare Realty Trust (HR)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Healthcare Realty Trust (NYSE:HR)

Receive News & Ratings for Healthcare Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthcare Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.